Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

Eur Urol. 2016 Sep;70(3):e72-4. doi: 10.1016/j.eururo.2016.02.049. Epub 2016 Mar 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Apoptosis Regulatory Proteins
  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms
  • Nivolumab

Substances

  • Antibodies, Monoclonal
  • Apoptosis Regulatory Proteins
  • Nivolumab